Roxadustat effectiveness versus ESAs in peritoneal dialysis patients during the COVID-19 pandemic: A...
Roxadustat effectiveness versus ESAs in peritoneal dialysis patients during the COVID-19 pandemic: A retrospective study
About this item
Full title
Author / Creator
Liu, Jie , Zhou, Kefan , Meng, Chen , Liu, Zhuzhu , Huang, Ruihua , Waheed, Yousuf , Yang, Fan , Liu, Kun , Zhao, Jiaqi , Zhang, Lin , Yu, Xiaoyan , Li, Shuang , Li, Tianyu , Tong, Yanshan , Wei, Xiaodan , Tian, Chuankuo , Sun, Dong and Zhou, Xinglei
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The COVID-19 pandemic has made treating renal anemia in chronic kidney disease (CKD) patients undergoing peritoneal dialysis (PD) difficult. The current study aims to compare roxadustat with erythropoiesis-stimulating agents (ESAs) during the COVID-19 pandemic.
We conducted a single-center, retrospective study during the COVID-19 outbreak in Chi...
Alternative Titles
Full title
Roxadustat effectiveness versus ESAs in peritoneal dialysis patients during the COVID-19 pandemic: A retrospective study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_3181720864
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_3181720864
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0320536
